TGV Sraac Ltd
Incorporated in 1981, TGV SRAAC Ltd is a flagship company of the TGV Group. It manufactures Chlor-Alkali products, Castor Derivatives and Fatty Acids[1]
- Market Cap ₹ 869 Cr.
- Current Price ₹ 81.1
- High / Low ₹ 133 / 80.8
- Stock P/E 12.4
- Book Value ₹ 101
- Dividend Yield 1.23 %
- ROCE 38.0 %
- ROE 40.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.80 times its book value
- Company has delivered good profit growth of 64.9% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chlor Alkali / Soda Ash
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
782 | 817 | 769 | 777 | 816 | 908 | 1,046 | 1,205 | 1,040 | 1,009 | 1,525 | 2,326 | 1,707 | |
681 | 695 | 670 | 669 | 710 | 776 | 866 | 974 | 884 | 860 | 1,219 | 1,786 | 1,521 | |
Operating Profit | 101 | 121 | 99 | 108 | 107 | 132 | 180 | 231 | 157 | 149 | 306 | 539 | 185 |
OPM % | 13% | 15% | 13% | 14% | 13% | 15% | 17% | 19% | 15% | 15% | 20% | 23% | 11% |
5 | 4 | -19 | 0 | 5 | 9 | 7 | -6 | 8 | 10 | 7 | 6 | 36 | |
Interest | 42 | 45 | 40 | 40 | 44 | 60 | 58 | 71 | 44 | 48 | 35 | 30 | 25 |
Depreciation | 37 | 41 | 36 | 36 | 35 | 47 | 77 | 58 | 56 | 63 | 69 | 74 | 81 |
Profit before tax | 28 | 40 | 4 | 32 | 33 | 34 | 53 | 95 | 64 | 48 | 209 | 442 | 115 |
Tax % | 50% | 6% | -11% | 30% | 26% | 52% | 44% | 28% | 26% | 40% | 36% | 18% | |
14 | 38 | 5 | 22 | 24 | 17 | 30 | 68 | 47 | 29 | 134 | 362 | 85 | |
EPS in Rs | 5.31 | 0.64 | 2.81 | 2.95 | 1.90 | 3.22 | 7.08 | 4.65 | 2.70 | 12.53 | 33.77 | 7.95 | |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 3% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 17% |
3 Years: | 31% |
TTM: | -27% |
Compounded Profit Growth | |
---|---|
10 Years: | 25% |
5 Years: | 65% |
3 Years: | 97% |
TTM: | -82% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 14% |
3 Years: | 49% |
1 Year: | -13% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 21% |
3 Years: | 24% |
Last Year: | 40% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 68 | 71 | 75 | 79 | 83 | 87 | 92 | 97 | 102 | 107 | 107 | 107 | 107 |
Reserves | 135 | 172 | 177 | 199 | 227 | 258 | 290 | 373 | 430 | 503 | 636 | 939 | 979 |
Preference Capital | 19 | 19 | 19 | 19 | 19 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | |
385 | 322 | 313 | 327 | 432 | 457 | 439 | 328 | 420 | 499 | 461 | 234 | 238 | |
207 | 212 | 231 | 213 | 230 | 276 | 269 | 298 | 323 | 344 | 393 | 403 | 360 | |
Total Liabilities | 794 | 777 | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 | 1,684 |
460 | 456 | 431 | 444 | 660 | 698 | 669 | 636 | 808 | 774 | 902 | 1,042 | 1,023 | |
CWIP | 53 | 70 | 126 | 124 | 0 | 0 | 13 | 77 | 29 | 125 | 55 | 11 | 53 |
Investments | 2 | 2 | 2 | 2 | 2 | 9 | 14 | 10 | 8 | 89 | 89 | 31 | 36 |
279 | 250 | 237 | 248 | 309 | 371 | 394 | 373 | 430 | 465 | 551 | 600 | 572 | |
Total Assets | 794 | 777 | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 | 1,684 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
105 | 27 | 78 | 65 | 50 | 142 | 153 | 202 | 122 | 132 | 168 | 429 | |
-67 | -53 | -75 | -52 | -132 | -109 | -75 | -55 | -188 | -163 | -147 | -169 | |
-2 | -3 | -12 | -2 | 91 | -33 | -76 | -145 | 65 | 58 | -38 | -255 | |
Net Cash Flow | 36 | -29 | -9 | 11 | 9 | -0 | 2 | 2 | -0 | 26 | -18 | 5 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 31 | 27 | 25 | 25 | 29 | 30 | 37 | 30 | 29 | 36 | 56 | 36 |
Inventory Days | 71 | 60 | 77 | 50 | 82 | 79 | 89 | 125 | 167 | 126 | 101 | 90 |
Days Payable | 66 | 74 | 93 | 65 | 77 | 98 | 80 | 67 | 73 | 81 | 66 | 42 |
Cash Conversion Cycle | 36 | 13 | 8 | 10 | 34 | 11 | 45 | 89 | 123 | 81 | 90 | 84 |
Working Capital Days | 16 | 3 | -9 | -1 | 21 | 7 | 11 | 35 | 46 | 37 | 61 | 40 |
ROCE % | 12% | 14% | 12% | 13% | 11% | 12% | 13% | 22% | 12% | 9% | 21% | 38% |
Documents
Announcements
- Closure of Trading Window 26 Mar
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 22 Mar
- Intimation Regarding Increase In Production Capacities Of Caustic Soda And Chloromethanes Divisions. 9 Mar
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 21 Feb
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Feb - Submission of un-audited financial results for the quarter and nine months ended 31.12.2023 published in newspapers.
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Profile:[1]
Company's operations are divided into 3 segments viz. Chemicals Division, Oils and Fats Division and Power Division.
a) Castor Derivatives:[2] Hydrogenated Castor Oil, 12-Hydroxy Stearic Acid, Ricinoleic Acid, Refined Castor Oil, Methyl, etc.
b) Chlor-Alkali Products:[3] Caustic Soda, Liquid Chlorine, Hydrochloric Acid, Caustic Potash, Sodium Hypochlorite (Liquid), Barium Sulphate (Precipitated powder), Hydrogen Gas, Potassium Carbonate
c) Fatty Acids:[4] Stearic Acid, Soap Noodles, Glycerine (Refined
/ Chemically Pure), Hydrogenated Palm Stearin
d) Chloromethanes:[5] Methyl Chloride, Methylene Chloride, Chloroform, Carbon Tetra Chloride
e) Toilet Soap:[6] Royal Saffron Sandal, Cool Lime, Royal HE-MAN, Baby Doctor, Royal Rose
f) Power Projects:[7][8]
Company has established power generation for captive use and for commercial purposes. There are no commercial operations at Bellary Power Plant due to expiry of Power Purchase Agreement (PPA) by KPTCL. Company is looking out for other viable options including its sale or relocation of the Plant